Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru

Trial Profile

Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs Lactobacillus reuteri (Primary)
  • Indications Acute enterocolitis; Gastrointestinal disorders; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Aug 2016 Status changed from not yet recruiting to completed.
    • 20 Nov 2014 According to ClinicalTrial.gov record, planned primary completion date changed from 1 Aug 2014 to 1 Jun 2015.
    • 20 Nov 2014 According to ClinicalTrial.gov record, planned initiation date changed from 1 Apr 2014 to 1 Feb 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top